Management of Cutaneous Melanoma
Top Cited Papers
- 2 September 2004
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 351 (10), 998-1012
- https://doi.org/10.1056/nejmra041245
Abstract
Cutaneous melanoma remains a management challenge. This year an estimated 55,000 Americans will receive a diagnosis of cutaneous melanoma, and 7900 will die from the disease. The authors of this review discuss the pathogenesis and management of cutaneous melanoma and provide perspective on treatment options.Keywords
This publication has 82 references indexed in Scilit:
- Excision Margins in High-Risk Malignant MelanomaThe New England Journal of Medicine, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Clinical Outcome of Stage I/II Melanoma Patients After Selective Sentinel Lymph Node Dissection: Long-Term Follow-Up ResultsJournal of Clinical Oncology, 2003
- A population‐based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivorsCancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Melanoma/skin cancer screening clinics: Experiences in the NetherlandsJournal of the American Academy of Dermatology, 1991
- Thin Stage I Primary Cutaneous Malignant MelanomaThe New England Journal of Medicine, 1988
- Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsThe New England Journal of Medicine, 1977